| Literature DB >> 25421757 |
Philipp M Antoni1, Anu Naik, Ina Albert, Riccardo Rubbiani, Susmita Gupta, Pilar Ruiz-Sanchez, Pornkanok Munikorn, José M Mateos, Vera Luginbuehl, Patchanita Thamyongkit, Urs Ziegler, Gilles Gasser, Gunnar Jeschke, Bernhard Spingler.
Abstract
Novel photoactive (metallo)porphyrins were synthesised and characterised. When irradiated with light at a wavelength greater than 600 nm, these porphyrins act as photosensitisers and show high cytotoxicity towards two different human cancer cell lines with IC50 values down to 0.4 μM. A paramagnetic copper(II) porphyrin is the first photosensitiser to display excellent phototoxicity, explained by the electron paramagnetic resonance (EPR) spin trapping of hydroxy radicals and experimentally confirmed by the discovery of elevated levels of reactive oxygen species (ROS) inside A2780 cells after irradiation with red light. This finding indicates that paramagnetic compounds should be considered for photodynamic therapy (PDT). Furthermore, an additive effect of cisplatin and a zinc porphyrin, both at subtherapeutic concentrations of 0.22 μM, was observed.Entities:
Keywords: EPR spectroscopy; anticancer agents; photodynamic therapy; porphyrinoids
Mesh:
Substances:
Year: 2014 PMID: 25421757 DOI: 10.1002/chem.201405470
Source DB: PubMed Journal: Chemistry ISSN: 0947-6539 Impact factor: 5.236